×
For best experience we recommend to activate Javascript in your browser.
Oncostatin M antibody (AA 26-220)
The Rabbit Polyclonal anti-Oncostatin M antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect Oncostatin M in samples from Human.
Quick Overview for Oncostatin M antibody (AA 26-220) (ABIN7623917)
Target
See all Oncostatin M (OSM) Antibodies
Oncostatin M (OSM)
Reactivity
All reactivities for Oncostatin M antibodies
Human
Host
All hosts for Oncostatin M antibodies
Rabbit
Clonality
All clonalities for Oncostatin M antibodies
Polyclonal
Conjugate
All conjugates for Oncostatin M antibodies
This Oncostatin M antibody is un-conjugated
Application
All applications for Oncostatin M antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-Oncostatin M Antibody
(hide)
Binding Specificity
All epitopes for Oncostatin M antibodies
AA 26-220
Purpose
Oncostatin M (OSM) Polyclonal Antibody
Sequence
Ala26~Arg220
Characteristics
The Oncostatin M (OSM) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
1 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for Oncostatin M
(hide)
Target
Oncostatin M (OSM)
Alternative Name
OSM
Gene ID
5008
UniProt
P13725
Pathways
JAK-STAT Signaling , Negative Regulation of Hormone Secretion
Recently viewed
(hide)
Chat with us , powered by LiveChat